Target Name: NME9
NCBI ID: G347736
Review Report on NME9 Target / Biomarker Content of Review Report on NME9 Target / Biomarker
NME9
Other Name(s): NXL2 | Thioredoxin-like 2 | NME/NM23 family member 9 | NM23-H9 | Thioredoxin domain-containing protein 6 | thioredoxin-like protein 2 | TXNDC6 | TXL2 | NME/NM23 family member 9, transcript variant 2 | Txl-2 | TXL-2 | NME9 variant 2 | NME gene family member 9 | Thioredoxin domain-containing protein 6 (isoform b) | Thioredoxin domain containing 6 | MGC129586 | Thioredoxin-like protein 2 | TXND6_HUMAN

NME9: Key Regulator of Cell Growth and Stress

NME9 (NXL2) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a key regulator of cell growth and differentiation, and is involved in the development and maintenance of tissues. NME9 has also been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, NME9 has generated a lot of interest as a potential drug target or biomarker.

One of the key features of NME9 is its ability to regulate the size and shape of cells. NME9 is a transcription factor that is involved in the regulation of gene expression, and has been shown to play a role in the development of various tissues and organs. NME9 has been shown to promote the production of large, round cells in the brain, which are thought to be an important step in the development of neural stem cells.

In addition to its role in cell growth and differentiation, NME9 has also been shown to play a role in the regulation of cellular stress. NME9 has been shown to help cells cope with stress caused by various factors, including changes in oxygen levels and the availability of nutrients. This may help NME9 to promote the survival and proliferation of cells that are under stress.

Another important function of NME9 is its role in the regulation of inflammation. NME9 has been shown to help cells respond to inflammatory stimuli, and may play a role in the development of inflammatory diseases. For example, NME9 has been shown to promote the production of immune cells in the body, which may help to protect against infection.

In addition to its role in cell growth, differentiation, and stress response, NME9 has also been shown to play a role in the regulation of cellular signaling pathways. NME9 has been shown to interact with a variety of signaling molecules, including TGF-beta, a key regulator of cell growth and differentiation. This may help NME9 to promote the growth and development of tissues and organs, and may also play a role in the development of various diseases.

Overall, NME9 is a protein that has a number of important functions in the body, including its role in cell growth and differentiation, stress response, and inflammation. As a result, NME9 has generated a lot of interest as a potential drug target or biomarker. Further research is needed to fully understand the role of NME9 in various biological processes, and to determine its potential as a therapeutic agent.

Protein Name: NME/NM23 Family Member 9

Functions: May be a regulator of microtubule physiology

The "NME9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NME9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NMI | NMNAT1 | NMNAT2 | NMNAT3 | NMRAL1 | NMRAL2P | NMRK1 | NMRK2 | NMS | NMT1 | NMT2 | NMTRQ-TTG10-1 | NMTRQ-TTG12-1 | NMTRV-TAC1-1 | NMU | NMUR1 | NMUR2 | NNAT | NNMT | NNT | NNT-AS1 | NOA1 | NOB1 | NOBOX | NOC2L | NOC2LP2 | NOC3L | NOC4L | NOCT | NOD1 | NOD2 | NODAL | NOG | NOL10 | NOL11 | NOL12 | NOL3 | NOL4 | NOL4L | NOL4L-DT | NOL6 | NOL7 | NOL8 | NOL9 | NOLC1 | NOM1 | NOMO1 | NOMO2 | NOMO3 | Non-protein coding RNA 185 | NONO | NOP10 | NOP14 | NOP14-AS1 | NOP16 | NOP2 | NOP53 | NOP56 | Nop56p-associated pre-rRNA complex | NOP58 | NOP9 | NOPCHAP1 | NORAD | NOS1 | NOS1AP | NOS2 | NOS2P1 | NOS2P2 | NOS2P3 | NOS3 | NOSIP | NOSTRIN | Notch ligands | Notch receptor | Notch Transcriptional Activation Complex | NOTCH1 | NOTCH2 | NOTCH2NLA | NOTCH2NLC | NOTCH3 | NOTCH4 | NOTO | NOTUM | NOVA1 | NOVA1-DT | NOVA2 | NOX1 | NOX3 | NOX4 | NOX5 | NOXA1 | NOXO1 | NOXRED1 | NPAP1 | NPAP1P2 | NPAP1P9 | NPAS1 | NPAS2 | NPAS3 | NPAS4